Development of prototype phased array ultrasound systems for hyperthermia and targeted drug delivery

Authors

  • Don Chorman Dept. of Electrical and Computer Engineering, Michigan State University, East Lansing, MI 48824, United States
  • Robert J. McGough Dept. of Electrical and Computer Engineering, Michigan State University, East Lansing, MI 48824, United States

Keywords:

Ablation, Cavitation, Computer simulation, Controlled drug delivery, Drug products, Thermal effects, High power phased array ultrasound (US) systems, Hyperthermia, Targeted drug delivery, Thermal ablation

Abstract

The development of high power phased array ultrasound (US) systems used to generate and direct both moderate temperature hyperthermia and high temperature thermal ablation is discussed. The effects of hyperthermia and cavitation can also be utilized as activation mechanisms in targeted drug delivery. The one-dimensional prototype arrays are constructed from PZT (Navy Type III) and double-sized copper-clad Pyralux baffles. The system is tested after the ultrasound phased array is mounted in a water tank. It is found that the shape of the measured field in the direction of the array sampling is similar to the results obtained from computer simulations.

Downloads

Published

2005-09-01

How to Cite

1.
Chorman D, McGough RJ. Development of prototype phased array ultrasound systems for hyperthermia and targeted drug delivery. Canadian Acoustics [Internet]. 2005 Sep. 1 [cited 2023 May 30];33(3):88-9. Available from: https://jcaa.caa-aca.ca/index.php/jcaa/article/view/1758

Issue

Vol. 33 No. 3 (2005)

Section

Proceedings of the Acoustics Week in Canada

License

Copyright on articles is held by the author(s). The corresponding author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide exclusive licence (or non-exclusive license for government employees) to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future)
i)    to publish, reproduce, distribute, display and store the Contribution;
ii)    to translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or, abstracts of the Contribution;
iii)    to exploit all subsidiary rights in the Contribution,
iv)    to provide the inclusion of electronic links from the Contribution to third party material where-ever it may be located;
v)    to licence any third party to do any or all of the above.